আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 2 mg
orion corporation - perphenazinum inn - húðuð tafla - 2 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ondansetron fresenius kabi stungulyf, lausn 2 mg/ml
fresenius kabi ab - ondansetronum hýdróklóríð - stungulyf, lausn - 2 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 4 mg
orion corporation - perphenazinum inn - húðuð tafla - 4 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
peratsin húðuð tafla 8 mg
orion corporation - perphenazinum inn - húðuð tafla - 8 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
zofran filmuhúðuð tafla 4 mg
sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 4 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
zofran filmuhúðuð tafla 8 mg
sandoz a/s - ondansetronum hýdróklóríð - filmuhúðuð tafla - 8 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
zofran mixtúra, lausn 0,8 mg/ml
sandoz a/s - ondansetronum hýdróklóríð - mixtúra, lausn - 0,8 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taflotan sine (taflotan) augndropar, lausn 15 míkróg/ml
santen oy* - tafluprostum inn - augndropar, lausn - 15 míkróg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml
santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
azopt
novartis europharm limited - brínzólamíð - glaucoma, open-angle; ocular hypertension - augnlækningar - azopt er ætlað að minnka hækkað í auga þrýsting í augu háþrýstingur;opna-horn glaucomaas sér í fullorðinn sjúklingar daufur að beta-blokkum eða í fullorðinn sjúklinga sem beta-blokkum eru handa, eða eins og venjulega meðferð til að beta-blokkum eða prostaglandín hliðstæðum.